Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA's Slim October User Fee Calendar Brings Some Controversy
Sep 30 2024
•
By
Bridget Silverman
Fewer FDA approvals are expected in October compared to the prior month, based on the number of user fee goals. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers